NDC 0074-1824 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0074-1824
- Package NDCs from labels
- 0074-1824-30
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0074-1824-30 | Novocain | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 1 | |
| 0074-1824-30 | Novocain | 100 in 1 CASE | INJECTION, SOLUTION | 100 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Potassium Acetate | POTASSIUM ACETATE | Hospira, Inc. | 8123cce8-42e3-49e4-a488-3bb836ecccd0 | 2026-04-09 | Warnings, Adverse reactions | Hospira, Inc. |
| FENTANYL CITRATE | FENTANYL CITRATE | Hospira, Inc. | 1ed25b2c-334e-4021-ada1-3396f07630dc | 2026-04-07 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Bupivacaine Spinal | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | Hospira, Inc. | 7a8d2539-4422-4312-0298-207ef1a2948e | 2026-04-07 | Warnings, Adverse reactions | Hospira, Inc. |
| Deferoxamine Mesylate | DEFEROXAMINE MESYLATE | Hospira, Inc. | f9ab6b1c-98d0-4373-0e9b-b10cb4a67543 | 2026-04-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | ea9f4498-0d43-4043-8dd1-f22537841c21 | 2026-04-06 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 8664c7ce-707b-4c6c-9ce4-7160b5f877f8 | 2026-04-06 | Warnings, Adverse reactions | Hospira, Inc. |
| BACTERIOSTATIC SODIUM CHLORIDE | SODIUM CHLORIDE | Hospira, Inc. | 376093e7-e09e-4a57-3199-195e45251866 | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | f2901045-904f-47bd-74a1-c561facd7f25 | 2026-04-01 | Warnings, Adverse reactions | Hospira, Inc. |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | c9ea31ec-4c26-452f-b07b-c5f894212cd5 | 2026-04-01 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | ce9a7469-c4ba-4f60-8f7a-47ef0974316e | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | c91ede49-c7cc-47b7-0f93-e6841dd5916a | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | abc41ed1-9512-4bea-9295-1a9ca134b6c2 | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | c3be2468-45e8-4ecc-a30b-e966743a563f | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | 6c181d7e-aed2-4975-30ac-d39a94cca7ec | 2026-03-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | Hospira, Inc. |
| Rocuronium Bromide | ROCURONIUM BROMIDE | Hospira, Inc. | 309aeb1b-8022-4df7-8194-ae6529e3395c | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | 018a8807-1331-41c3-4889-c7ec502a9043 | 2026-03-09 | Warnings, Adverse reactions | Sodium Chloride Hospira, Inc. |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.